Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
Author:
Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu FORCID, Ordóñez G R, Rovira J, Clot G, Royo C, Navarro A, Gonzalez-Farre B, Vaghefi A, Castellano G, Rubio-Perez C, Tamborero D, Briones J, Salar A, Sancho J M, Mercadal S, Gonzalez-Barca E, Escoda L, Miyoshi H, Ohshima K, Miyawaki K, Kato K, Akashi K, Mozos A, Colomo L, Alcoceba MORCID, Valera A, Carrió A, Costa D, Lopez-Bigas N, Schmitz R, Staudt L M, Salaverria I, López-Guillermo A, Campo EORCID
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference62 articles.
1. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Fourth edition. IARC Press: Lyon, 2008. 2. Coiffier B . Rituximab therapy in malignant lymphoma. Oncogene 2007; 26: 3603–3613. 3. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511. 4. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New Engl J Med 2002; 346: 1937–1947. 5. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282.
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|